![Steven Cha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Steven Cha worked as Chief Medical Officer at Imugene Ltd. in 2022.
Dr. Cha worked as Chief Medical Officer at NKGen Operating Biotech, Inc. Dr. Cha worked as Senior Vice President-Clinical Research at Processa Pharmaceuticals, Inc. Dr. Cha completed undergraduate studies at the University of California San Diego and earned a doctorate from Tufts University School of Medicine.
Former positions of Steven Cha
| Companies | Position | End |
|---|---|---|
| IMUGENE LIMITED | Chief Tech/Sci/R&D Officer | 01/06/2022 |
| PROCESSA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Chief Tech/Sci/R&D Officer | - |
Training of Steven Cha
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Health Technology |
- Stock Market
- Insiders
- Steven Cha
